All In MedTech

FDA Clearance Tracker · P970013

MICRONY PACEMAKERS

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Dec 21, 2000 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Dec 21, 2000

Approved

Time to decision

1,448 days

Received Jan 3, 1997. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P970013
Device name
MICRONY PACEMAKERS
Applicant location
Sylmar, CA
Received
Jan 3, 1997
Decided
Dec 21, 2000
Decision
Approved
Supplements
94 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LWO

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE MICRONY(TM) SR+ MODEL 2425T SINGLE CHAMBER RATE ADAPTIVE PULSE GENERATOR, WHICH IS PROGRAMMED WITH THE APS II PROGRAMMER WITH MODLE 3204A SOFTWARE, THE APSU PROGRAMMER, AND THE MODEL 3500/3510 PROGRAMMER WITH MODEL 3304 SOFTWARE. THE DEIVCE IS INDICATED FOR THE FOLLOWING: 1) ACCEPTED PATIENT CONDITIONS WARRANTING CHRONIC CARDIAC PACING WHICH INCLUDE: SICK SINUS SYNDROME; CHRONIC, SYMPTOMATIC SECOND- AND THIRD-DEGREE AV BLOCK; RECURRENT ADAMS-STOKES SYNDROME; AND SYMTOMATIC BILATERAL BUNDLE BRANCH BLOCK WHEN TACHY-ARRHYTHMIA AND OTHER CAUSES HAVE BEEN RULED OUT. 2) ATRIAL PACING IN PATIENTS WITH SINUS NODE DYSFUNCTION AND NORMAL AV AND INTRAVENTRICULAR CONDUCTION SYSTEMS. 3) VENTRICULAR PACING IN PATIENTS WITH SIGNIFICANT BRADYCARDIA AND: NORMAL SINUS RHYTHM WITH ONLY RARE EPISODES OF AV BLOCK OR SINUS ARREST REQUIRING SHORT PERIODS OF PACING SUPPORT, CHRONIC ATRIAL FIBRILLATION, AND SEVERE PHYSICAL DISABILITY. 4) RATE-MODULATED PACING IN PATIENTS WHO WOULD BENEFIT FROM INCREASED PACING RATES CONCURRENT WITH PHYSICAL ACTIVITY.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LWO. The earliest in FDA's data is P850051, decided Jun 10, 1986.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.